A detailed history of Baker Bros. Advisors LP transactions in Insmed Inc stock. As of the latest transaction made, Baker Bros. Advisors LP holds 3,576,038 shares of INSM stock, worth $254 Million. This represents 3.18% of its overall portfolio holdings.

Number of Shares
3,576,038
Previous 343,000 942.58%
Holding current value
$254 Million
Previous $9.31 Million 2474.9%
% of portfolio
3.18%
Previous 0.12%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$22.0 - $69.71 $71.1 Million - $225 Million
3,233,038 Added 942.58%
3,576,038 $240 Million
Q1 2023

May 15, 2023

BUY
$16.26 - $21.73 $5.25 Million - $7.02 Million
323,050 Added 1619.3%
343,000 $5.85 Million
Q3 2022

Nov 14, 2022

SELL
$20.88 - $28.21 $44.6 Million - $60.3 Million
-2,136,051 Reduced 99.07%
19,950 $430,000
Q4 2020

Feb 16, 2021

SELL
$31.45 - $40.54 $3.67 Million - $4.73 Million
-116,711 Reduced 5.14%
2,156,001 $71.8 Million
Q3 2020

Nov 16, 2020

SELL
$26.0 - $34.5 $19.6 Million - $26 Million
-752,672 Reduced 24.88%
2,272,712 $73 Million
Q1 2020

May 15, 2020

BUY
$13.63 - $33.98 $7.91 Million - $19.7 Million
580,119 Added 23.72%
3,025,384 $48.5 Million
Q4 2019

Feb 14, 2020

BUY
$16.12 - $24.98 $3.47 Million - $5.38 Million
215,505 Added 9.66%
2,445,265 $58.4 Million
Q3 2019

Nov 14, 2019

SELL
$15.49 - $25.78 $3.6 Million - $5.99 Million
-232,456 Reduced 9.44%
2,229,760 $39.3 Million
Q2 2019

Aug 14, 2019

BUY
$23.0 - $32.19 $8.85 Million - $12.4 Million
384,615 Added 18.51%
2,462,216 $63 Million
Q1 2019

May 15, 2019

BUY
$13.91 - $31.15 $3.14 Million - $7.03 Million
225,619 Added 12.18%
2,077,601 $60.4 Million
Q3 2018

Nov 14, 2018

BUY
$18.95 - $28.08 $21.8 Million - $32.3 Million
1,151,982 Added 164.57%
1,851,982 $37.4 Million
Q3 2017

Nov 14, 2017

BUY
$11.61 - $31.21 $8.13 Million - $21.8 Million
700,000
700,000 $21.8 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.62B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Baker Bros. Advisors LP Portfolio

Follow Baker Bros. Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Baker Bros. Advisors LP with notifications on news.